Melanoma in pregnancy
- PMID: 29051777
- PMCID: PMC5637994
- DOI: 10.1177/1753495X17695001
Melanoma in pregnancy
Abstract
Melanoma is one of the most common cancers diagnosed in pregnancy and has a high metastatic potential. As the incidence of melanoma increases, careful clinical evaluation of suspicious skin lesions remains the mainstay of early diagnosis. There is controversy in the literature as to whether pregnancy-associated melanoma has worse survival than other melanomas. Any changing-pigmented lesion should be biopsied, regardless of pregnancy hyperpigmentation. Increased lymphangiogenesis in pregnancy is associated with increased metastasis - timely diagnosis is therefore imperative. While the effect of oestrogen and progesterone on melanoma is under investigation, it is generally accepted that oral contraceptive use in not contraindicated after a diagnosis of melanoma in pregnancy. Subsequent pregnancy should be delayed for two to three years after a diagnosis of melanoma with a high risk of recurrence.
Keywords: Pregnancy; malignancy; melanoma.
References
-
- Olesen AV, Parner ET, Mortensen PB, et al. Prenatal risk factors for cutaneous malignant melanoma: follow-up of 2,594,783 Danes Born from 1950 to 2002. Cancer Epidemiol Biomarkers Prev 2009; 18: 155–161. - PubMed
-
- Jhaveri MB, Driscoll MS, Grant-Kels JM. Melanoma in pregnancy. Clin Obstet Gynecol 2011; 54: 537–545. - PubMed
-
- Lens M, Bataille V. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes Control 2008; 19: 437–442. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials